Literature DB >> 6699173

Reactions of immunoglobulin G-binding ligands with platelets and platelet-associated immunoglobulin G.

W F Rosse, D V Devine, R Ware.   

Abstract

Immunoglobulin G (IgG) bound to platelets is usually detected by one of two general methods: binding of labeled anti-IgG or consumption of anti-IgG. The latter method gives, in general, values 5-10-fold greater than the former under the same conditions. To investigate these discrepancies, we have compared the detection of platelet-bound IgG by a labeled anti-IgG binding assay and by a quantitative antiglobulin consumption test using the same antibodies. The interaction of 125I-labeled monoclonal anti-IgG or polyclonal anti-IgG with washed and IgG-coated platelets was studied. The binding of these ligands to washed normal platelets was largely (50-80%) nonspecific; the binding was not saturable and was only partially inhibitable by excess unlabeled anti-IgG. The binding of anti-IgG to platelets coated with anti-PIA1, a platelet-specific IgG antibody, appeared to be saturable and inhibitable; the dissociation constant (KD) of this IgG-anti-IgG reaction was 4.9 X 10(-9) for monoclonal and 1.4 X 10(-7) for polyclonal anti-IgG. The ratio of sites present on the membrane (determined by 131I-labeled anti-PIA1) to the number of binding sites for anti-IgG determined by Scatchard analysis was 0.53 for monoclonal anti-IgG and 1.3 for polyclonal anti-IgG. The binding of monoclonal anti-IgG to platelet-bound immune complexes or IgG aggregates appeared to be complex. 131I-Labeled IgG was affixed to platelets and was detected by three tests: direct binding of radiolabeled monoclonal anti-IgG and quantitative antiglobulin consumption (QAC) tests, which were quantitated either by measuring directly the amount of radiolabeled anti-IgG consumed from fluid phase (direct QAC), or indirectly by reference to a calibration curve relating the consumption of anti-IgG by known amounts of fluid-phase, non-immune IgG (indirect QAC). The amount of platelet-bound IgG detected by the direct binding of 125I-labeled monoclonal anti-IgG and by the direct QAC approximated that known to be bound to the platelet. The results of the indirect QAC test were 10-fold greater. The discrepancy appears to be due to the fact that there is a difference between the IgG-anti-IgG interaction when IgG is bound to a platelet and when it is in solution or bound to plastic nonspecifically or specifically. This difference results in a falsely high value for platelet-bound IgG when fluid-phase or plastic-bound IgG is used to calibrate the antiglobulin consumption test.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699173      PMCID: PMC425040          DOI: 10.1172/JCI111235

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds.

Authors:  A NISONOFF; F C WISSLER; L N LIPMAN; D L WOERNLEY
Journal:  Arch Biochem Biophys       Date:  1960-08       Impact factor: 4.013

2.  Quantitative determination of antibody in idiopathic thrombocytopenic purpura. Correlation of serum and platelet-bound antibody with clinical response.

Authors:  R Dixon; W Rosse; L Ebbert
Journal:  N Engl J Med       Date:  1975-01-30       Impact factor: 91.245

3.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

4.  Detection and quantification of platelet-bound antibodies with immunoperoxidase.

Authors:  M Leporrier; G Dighiero; M Auzemery; J L Binet
Journal:  Br J Haematol       Date:  1979-08       Impact factor: 6.998

5.  A solid-phase radioimmunoassay for bound anti-platelet antibody: studies on 45 patients with autoimmune platelet disorders.

Authors:  K Hymes; S Shulman; S Karpatkin
Journal:  J Lab Clin Med       Date:  1979-10

6.  Platelet antibodies in thrombocytopenic patients.

Authors:  U M Hegde; E C Gordon-Smith; S Worlledge
Journal:  Br J Haematol       Date:  1977-01       Impact factor: 6.998

7.  Elevated platelet-associated IgG in the thrombocytopenia of septicemia.

Authors:  J G Kelton; P B Neame; J Gauldie; J Hirsh
Journal:  N Engl J Med       Date:  1979-04-05       Impact factor: 91.245

8.  Immune thrombocytopenia. Use of a Coombs antiglobulin test to detect IgG and C3 on platelets.

Authors:  D B Cines; A D Schreiber
Journal:  N Engl J Med       Date:  1979-01-18       Impact factor: 91.245

9.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

10.  Platelet-associated IgG in immune thrombocytopenic purpura.

Authors:  G A Luiken; R McMillan; A L Lightsey; P Gordon; S Zevely; I Schulman; T J Gribble; R L Longmire
Journal:  Blood       Date:  1977-08       Impact factor: 22.113

View more
  5 in total

1.  Platelet antibodies of the IgM class in immune thrombocytopenic purpura.

Authors:  D B Cines; S B Wilson; A Tomaski; A D Schreiber
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

2.  Restriction of the alternative pathway of human complement by intact Trypanosoma brucei subsp. gambiense.

Authors:  D V Devine; R J Falk; A E Balber
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

3.  Elevated numbers of gamma-delta (gamma delta+) T lymphocytes in children with immune thrombocytopenic purpura.

Authors:  R E Ware; T A Howard
Journal:  J Clin Immunol       Date:  1994-07       Impact factor: 8.317

4.  Pathophysiology of thrombocytopenia associated with HIV infection in homosexual men. A preliminary report.

Authors:  P J Ballem; A Belzberg; D Devine; P Doubroff; C Mikulash; B Spurston; H Chambers; C Sartori; N Buskard
Journal:  Blut       Date:  1989-07

5.  Identification of Fc and F(ab')2 IgG receptors on human platelets.

Authors:  S Vancura; M Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.